Cite
22 Dose Escalated Radiotherapy is Associated with Improved Outcomes for High Grade Meningioma.
MLA
Sahgal, Arjun, et al. “22 Dose Escalated Radiotherapy Is Associated with Improved Outcomes for High Grade Meningioma.” Radiotherapy & Oncology, vol. 186, Sept. 2023, p. S13. EBSCOhost, https://doi.org/10.1016/S0167-8140(23)89908-X.
APA
Sahgal, A., Myrehaug, S., Soliman, H., Tseng, C.-L., Detsky, J., Chen, H., Lim-Fat, M.-J., Ruschin, M., Atenafu, E., Keith, J., Lipsman, N., Heyn, C., Maralani, P., Das, S., Pirouzmand, F., & Zeng, K. L. (2023). 22 Dose Escalated Radiotherapy is Associated with Improved Outcomes for High Grade Meningioma. Radiotherapy & Oncology, 186, S13. https://doi.org/10.1016/S0167-8140(23)89908-X
Chicago
Sahgal, Arjun, Sten Myrehaug, Hany Soliman, Chia-Lin Tseng, Jay Detsky, Hanbo Chen, Mary-Jane Lim-Fat, et al. 2023. “22 Dose Escalated Radiotherapy Is Associated with Improved Outcomes for High Grade Meningioma.” Radiotherapy & Oncology 186 (September): S13. doi:10.1016/S0167-8140(23)89908-X.